BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ormond Filho AG, Carneiro BC, Pastore D, Silva IP, Yamashita SR, Consolo FD, Hungria VTM, Sandes AF, Rizzatti EG, Nico MAC. Whole-Body Imaging of Multiple Myeloma: Diagnostic Criteria. RadioGraphics 2019;39:1077-97. [DOI: 10.1148/rg.2019180096] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 6.7] [Reference Citation Analysis]
Number Citing Articles
1 Zanoni L, Mattana F, Calabrò D, Paccagnella A, Broccoli A, Nanni C, Fanti S. Overview and recent advances in PET/CT imaging in lymphoma and multiple myeloma. Eur J Radiol 2021;141:109793. [PMID: 34148014 DOI: 10.1016/j.ejrad.2021.109793] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
2 Pierro A, Posa A, Astore C, Sciandra M, Tanzilli A, Petrosino A, Del Balso MS, Fraticelli V, Cilla S, Iezzi R. Whole-Body Low-Dose Multidetector-Row CT in Multiple Myeloma: Guidance in Performing, Observing, and Interpreting the Imaging Findings. Life (Basel) 2021;11:1320. [PMID: 34947851 DOI: 10.3390/life11121320] [Reference Citation Analysis]
3 Ippolito D, Giandola T, Maino C, Gandola D, Ragusi M, Brambilla P, Bonaffini PA, Sironi S. Diagnostic Value of Whole-Body MRI Short Protocols in Bone Lesion Detection in Multiple Myeloma Patients. Diagnostics (Basel) 2021;11:1053. [PMID: 34201122 DOI: 10.3390/diagnostics11061053] [Reference Citation Analysis]
4 Dong H, Huang W, Ji X, Huang L, Zou D, Hao M, Deng S, Shen Z, Lu X, Wang J, Song Z, Zhang X, Xue H, Xia S. Prediction of Early Treatment Response in Multiple Myeloma Using MY-RADS Total Burden Score, ADC, and Fat Fraction From Whole-Body MRI: Impact of Anemia on Predictive Performance. AJR Am J Roentgenol 2021. [PMID: 34523949 DOI: 10.2214/AJR.21.26534] [Reference Citation Analysis]
5 Treitl KM, Ricke J, Baur-Melnyk A. Whole-body magnetic resonance imaging (WBMRI) versus whole-body computed tomography (WBCT) for myeloma imaging and staging. Skeletal Radiol 2021. [PMID: 34031705 DOI: 10.1007/s00256-021-03799-4] [Reference Citation Analysis]
6 Thomas E, Mathieu C, Moreno-Gaona P, Mittelheisser V, Lux F, Tillement O, Pivot X, Ghoroghchian PP, Detappe A. Anti-BCMA Immuno-NanoPET Radiotracers for Improved Detection of Multiple Myeloma. Adv Healthc Mater 2021;:e2101565. [PMID: 34710281 DOI: 10.1002/adhm.202101565] [Reference Citation Analysis]
7 Tore D, Rampado O, Guarnaccia C, Mina R, Oronzio M, Santonocito A, Serafini A, Strazzarino GA, Gianusso L, Bringhen S, Fonio P, Depaoli A. Ultra-Low-Dose Whole-Body Computed Tomography Protocol Optimization for Patients With Plasma Cell Disorders: Diagnostic Accuracy and Effective Dose Analysis From a Reference Center. Front Oncol 2021;11:769295. [PMID: 34869000 DOI: 10.3389/fonc.2021.769295] [Reference Citation Analysis]
8 Shapiro YN, O'Donnell EK. Oncologist perspective: role of imaging in myeloma. Skeletal Radiol 2021. [PMID: 34272993 DOI: 10.1007/s00256-021-03856-y] [Reference Citation Analysis]
9 Saad A, Azzopardi C, Haleem S, Czyz M, James SL, Botchu R. Tumours of the odontoid peg revisited. Indian J Radiol Imaging 2020;30:420-6. [PMID: 33737770 DOI: 10.4103/ijri.IJRI_363_20] [Reference Citation Analysis]
10 Cheung H, Yechoor A, Behnia F, Abadi AB, Khodarahmi I, Soltanolkotabi M, Shafiei M, Chalian M. Common Skeletal Neoplasms and Nonneoplastic Lesions at 18F-FDG PET/CT. Radiographics 2021;:210090. [PMID: 34919467 DOI: 10.1148/rg.210090] [Reference Citation Analysis]
11 Guimarães JB, da Cruz IAN, Ahlawat S, Ormond Filho AG, Nico MAC, Lederman HM, Fayad LM. The Role of Whole-Body MRI in Pediatric Musculoskeletal Oncology: Current Concepts and Clinical Applications. J Magn Reson Imaging 2021. [PMID: 34145692 DOI: 10.1002/jmri.27787] [Reference Citation Analysis]
12 Valenzuela RF, Madewell JE, Kundra V, Costelloe CM. Advanced Imaging in Musculoskeletal Oncology: Moving Away From RECIST and Embracing Advanced Bone and Soft Tissue Tumor Imaging (ABASTI)-Part II-Novel Functional Imaging Techniques. Semin Ultrasound CT MR 2021;42:215-27. [PMID: 33814107 DOI: 10.1053/j.sult.2020.08.013] [Reference Citation Analysis]
13 Caetano AP, Mascarenhas VV, Machado PM. Axial Spondyloarthritis: Mimics and Pitfalls of Imaging Assessment. Front Med (Lausanne) 2021;8:658538. [PMID: 33968964 DOI: 10.3389/fmed.2021.658538] [Reference Citation Analysis]
14 Ippolito D, Giandola T, Maino C, Gandola D, Ragusi M, Bonaffini PA, Sironi S. Whole Body Low Dose Computed Tomography (WBLDCT) Can Be Comparable to Whole-Body Magnetic Resonance Imaging (WBMRI) in the Assessment of Multiple Myeloma. Diagnostics (Basel) 2021;11:857. [PMID: 34064594 DOI: 10.3390/diagnostics11050857] [Reference Citation Analysis]
15 Spierling A, Kikano EG, Chagarlamudi K, Vos D, Rao S, Smith DA, Ramaiya NH. Imaging features of hypercalcemia: A primer for emergency radiologists. Clin Imaging 2021;80:215-24. [PMID: 34352494 DOI: 10.1016/j.clinimag.2021.07.016] [Reference Citation Analysis]
16 Ippolito D, Giandola T, Maino C, Pecorelli A, Ragusi M, Porta M, Gandola D, Franzesi CT, Sironi S. Whole-body low-dose computed tomography (WBLDCT) in staging and re-staging of multiple myeloma. Ann Hematol 2021;100:1241-9. [PMID: 33660034 DOI: 10.1007/s00277-021-04468-1] [Reference Citation Analysis]
17 Burns R, Mulé S, Blanc-Durand P, Tofighi M, Belhadj K, Zerbib P, Le Bras F, Baranes L, Haioun C, Itti E, Luciani A. Optimization of whole-body 2-[18F]FDG-PET/MRI imaging protocol for the initial staging of patients with myeloma. Eur Radiol 2021. [PMID: 34842956 DOI: 10.1007/s00330-021-08388-6] [Reference Citation Analysis]
18 Liu J, Wang C, Guo W, Zeng P, Liu Y, Lang N, Yuan H. A preliminary study using spinal MRI-based radiomics to predict high-risk cytogenetic abnormalities in multiple myeloma. Radiol Med 2021;126:1226-35. [PMID: 34159496 DOI: 10.1007/s11547-021-01388-y] [Reference Citation Analysis]
19 Łacina P, Butrym A, Humiński M, Dratwa M, Frontkiewicz D, Mazur G, Bogunia-Kubik K. Association of RANK and RANKL gene polymorphism with survival and calcium levels in multiple myeloma. Mol Carcinog 2021;60:106-12. [PMID: 33283899 DOI: 10.1002/mc.23272] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
20 Khodarahmi I, Alizai H, Chalian M, Alaia EF, Burke CJ, Slasky SE, Wenokor C. Imaging Spectrum of Calvarial Abnormalities. Radiographics 2021;41:1144-63. [PMID: 34197249 DOI: 10.1148/rg.2021200198] [Reference Citation Analysis]
21 Mena E. Modern radiographic imaging in multiple myeloma, what is the minimum requirement? Seminars in Oncology 2022. [DOI: 10.1053/j.seminoncol.2022.01.007] [Reference Citation Analysis]